GLOBAL HEALTHCARE STRATEGY

Strategic growth advisory

Understanding the potential offered by the EU framework for elective care treatment for a serious illness health insurance company

CLIENT

An EU-based, critical illness insurer

REQUIREMENT

Provide full data and interpretation of the recent EU health Directive on elective cross-border treatment: Can it provide an opportunity for a new product or service?

CHALLENGE

The client wished to understand the legislation and the complex real-life mechanics of a new EU Directive on elective cross-border health treatment. The scope was restricted to the Polish-German cross border health traffic. Was there a possiblility to use this to redcue claims and/or to create a product around this?

SOLUTION

MGG tapped multiple primary and secondary sources - eg all the EU reports on this over 5 years, interviews with the key info points in the 2 countries and other benchmark service companies plus an assessment of all the info provided by the countries - to understand and assess the EU Directive and its rules.

EXAMPLE OUTPUT

Case study #4 example output image

THE OUTCOME

The client decided was advised NOT to commercialise the Directive as insurers were prohibited from reimbursement and the patient flows were too low.